143 related articles for article (PubMed ID: 30340896)
1. Discovery of 5-(2-chloro-4'-(1H-imidazol-1-yl)-[1,1'-biphenyl]-4-yl)-1H-tetrazole as potent and orally efficacious S-nitrosoglutathione reductase (GSNOR) inhibitors for the potential treatment of COPD.
Muthukaman N; Deshmukh S; Tondlekar S; Tambe M; Pisal D; Sarode N; Mhatre S; Chakraborti S; Shah D; Bhosale VM; Kulkarni A; Mahat MYA; Jadhav SB; Gudi GS; Khairatkar-Joshi N; Gharat LA
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3766-3773. PubMed ID: 30340896
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Mutka SC; Stout AM; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5849-53. PubMed ID: 21855338
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Blonder JP; Colagiovanni DB; Stout AM; Mutka SC; Richards JP; Rosenthal GJ
Bioorg Med Chem Lett; 2012 Mar; 22(6):2338-42. PubMed ID: 22342142
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.
Sun X; Qiu J; Strong SA; Green LS; Wasley JW; Colagiovanni DB; Mutka SC; Blonder JP; Stout AM; Richards JP; Chun L; Rosenthal GJ
Bioorg Med Chem Lett; 2011 Jun; 21(12):3671-5. PubMed ID: 21570838
[TBL] [Abstract][Full Text] [Related]
5. O-Aminobenzoyl-S-nitrosoglutathione: A fluorogenic, cell permeable, pseudo-substrate for S-nitrosoglutathione reductase.
Sun BL; Palmer L; Alam SR; Adekoya I; Brown-Steinke K; Periasamy A; Mutus B
Free Radic Biol Med; 2017 Jul; 108():445-451. PubMed ID: 28419866
[TBL] [Abstract][Full Text] [Related]
6. Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
Sun X; Wasley JW; Qiu J; Blonder JP; Stout AM; Green LS; Strong SA; Colagiovanni DB; Richards JP; Mutka SC; Chun L; Rosenthal GJ
ACS Med Chem Lett; 2011 May; 2(5):402-6. PubMed ID: 24900320
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.
Chen Q; Sievers RE; Varga M; Kharait S; Haddad DJ; Patton AK; Delany CS; Mutka SC; Blonder JP; Dubé GP; Rosenthal GJ; Springer ML
J Appl Physiol (1985); 2013 Mar; 114(6):752-60. PubMed ID: 23349456
[TBL] [Abstract][Full Text] [Related]
8. The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.
Barnett SD; Buxton ILO
Crit Rev Biochem Mol Biol; 2017 Jun; 52(3):340-354. PubMed ID: 28393572
[TBL] [Abstract][Full Text] [Related]
9. A nonclinical safety and pharmacokinetic evaluation of N6022: a first-in-class S-nitrosoglutathione reductase inhibitor for the treatment of asthma.
Colagiovanni DB; Drolet DW; Langlois-Forget E; Piché MP; Looker D; Rosenthal GJ
Regul Toxicol Pharmacol; 2012 Feb; 62(1):115-24. PubMed ID: 22210450
[TBL] [Abstract][Full Text] [Related]
10. AKR1A1 is a novel mammalian
Stomberski CT; Anand P; Venetos NM; Hausladen A; Zhou HL; Premont RT; Stamler JS
J Biol Chem; 2019 Nov; 294(48):18285-18293. PubMed ID: 31649033
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of S-Nitrosoglutathione Controls Cigarette Smoke-Induced Inflammatory-Oxidative Stress and Chronic Obstructive Pulmonary Disease-Emphysema Pathogenesis by Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function.
Bodas M; Silverberg D; Walworth K; Brucia K; Vij N
Antioxid Redox Signal; 2017 Sep; 27(7):433-451. PubMed ID: 28006950
[TBL] [Abstract][Full Text] [Related]
12. Nebivolol Acts as a S-Nitrosoglutathione Reductase Inhibitor: A New Mechanism of Action.
Jiang H; Polhemus DJ; Islam KN; Torregrossa AC; Li Z; Potts A; Lefer DJ; Bryan NS
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):478-85. PubMed ID: 26746429
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase.
Sanghani PC; Davis WI; Fears SL; Green SL; Zhai L; Tang Y; Martin E; Bryan NS; Sanghani SP
J Biol Chem; 2009 Sep; 284(36):24354-62. PubMed ID: 19596685
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of inhibition for N6022, a first-in-class drug targeting S-nitrosoglutathione reductase.
Green LS; Chun LE; Patton AK; Sun X; Rosenthal GJ; Richards JP
Biochemistry; 2012 Mar; 51(10):2157-68. PubMed ID: 22335564
[TBL] [Abstract][Full Text] [Related]
15. ADH IB expression, but not ADH III, is decreased in human lung cancer.
Mutka SC; Green LH; Verderber EL; Richards JP; Looker DL; Chlipala EA; Rosenthal GJ
PLoS One; 2012; 7(12):e52995. PubMed ID: 23285246
[TBL] [Abstract][Full Text] [Related]
16. Ventilatory responses during and following exposure to a hypoxic challenge in conscious mice deficient or null in S-nitrosoglutathione reductase.
Palmer LA; May WJ; deRonde K; Brown-Steinke K; Bates JN; Gaston B; Lewis SJ
Respir Physiol Neurobiol; 2013 Feb; 185(3):571-81. PubMed ID: 23183419
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.
Blonder JP; Mutka SC; Sun X; Qiu J; Green LH; Mehra NK; Boyanapalli R; Suniga M; Look K; Delany C; Richards JP; Looker D; Scoggin C; Rosenthal GJ
BMC Pulm Med; 2014 Jan; 14():3. PubMed ID: 24405692
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug.
Kim YW; Kim YK; Lee JY; Chang KT; Lee HJ; Kim DK; Sheen YY
Xenobiotica; 2008 Mar; 38(3):325-39. PubMed ID: 18274960
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a Novel Series of Imidazo[1,2-a]pyrimidine Derivatives as Potent and Orally Bioavailable Lipoprotein-Associated Phospholipase A2 Inhibitors.
Chen X; Xu W; Wang K; Mo M; Zhang W; Du L; Yuan X; Xu Y; Wang Y; Shen J
J Med Chem; 2015 Nov; 58(21):8529-41. PubMed ID: 26479945
[TBL] [Abstract][Full Text] [Related]
20. Increased nitrosoglutathione reductase activity in hypoxic pulmonary hypertension in mice.
Wu X; Du L; Xu X; Tan L; Li R
J Pharmacol Sci; 2010; 113(1):32-40. PubMed ID: 20431245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
